Web Toolbar by Wibiya
Login | Sign Up AnonymousUser
twiter
New to Comunitee?


or Sign Up with Email

Business

>> CANTOR FITZGERALD Latest News

JAN 04, 2013 - Benzinga

A Must Read - Share

UPDATE: Cantor Fitzgerald Downgrades Ligand Pharmaceuticals to Hold, Lowers PT

In a report published Friday, Cantor Fitzgerald downgraded its rating on Ligand Pharmaceuticals (NASDAQ: LGND) from Buy to Hold, and lowered its price target from $28.00 to $23.00. Cantor Fitzgerald noted, “After attending a Hepatitis C lecture and speaking with physicians at the New York Society for Gastrointestinal Endoscopy on December 19 we ar

Tags: UPDATE: Cantor Fitzgerald Downgrades Ligand Pharmaceuticals to Hold, Lowers PT,  Cantor Fitzgerald Latest News